Snowden, John A. http://orcid.org/0000-0001-6819-3476
Sánchez-Ortega, Isabel
Corbacioglu, Selim
Basak, Grzegorz W. http://orcid.org/0000-0003-3858-8180
Chabannon, Christian http://orcid.org/0000-0002-3755-4889
de la Camara, Rafael http://orcid.org/0000-0002-8189-5779
Dolstra, Harry
Duarte, Rafael F.
Glass, Bertram
Greco, Raffaella http://orcid.org/0000-0002-6117-5328
Lankester, Arjan C. http://orcid.org/0000-0002-6703-2993
Mohty, Mohamad http://orcid.org/0000-0002-7264-808X
Neven, Bénédicte
de Latour, Régis Peffault
Pedrazzoli, Paolo http://orcid.org/0000-0002-9419-7160
Peric, Zinaida http://orcid.org/0000-0001-9458-8025
Yakoub-Agha, Ibrahim http://orcid.org/0000-0003-4524-8782
Sureda, Anna
Kröger, Nicolaus http://orcid.org/0000-0001-5103-9966
,
Article History
Received: 22 March 2022
Revised: 15 April 2022
Accepted: 20 April 2022
First Online: 19 May 2022
Competing interests
: BG discloses employment and management position by Helios; advisory/expert activity by Roche, Celgene, BMS, Gilead, Janssen, Novartis, Riemser, MSD and Jazz; honoraria by BMS, Celgene, Novartis, Roche, Riemser, Janssen, MSD, Jazz and funding scientific research by Roche, Celgene and Amgen. RG discloses speaking honoraria from educational events supported by Biotest, Pfizer, Medac and Magenta. ACL discloses consultancy and research support by Neovii Biotec. MM discloses honoraria by Adaptive Biotechnologies, Amgen, Astellas, Celgene-BMS, GSK, Gilead, Janssen, Jazz Pharmaceuticals, Novartis, Oncopeptides, Pfizer, Sanofi, Takeda and research funding by Janssen and Sanofi. RPL discloses expert consultant/speaker’s fees by Alexion, Amgen, Gilead, Jazz, Keocyte, MSD, Novartis, Pfizer, Roche, Samsung and Sobi and research grant by Alexion, Amgen, Jazz pharmaceutical, Novartis and Pfizer. AS discloses honoraria by Takeda, BMS/Celgene, MSD, Janssen, Amgen, Novartis, Gilead Kite, Sanofi, Roche and Alexion; consultancy by Takeda, BMS/Celgene, Novartis, Janssen, Gilead and Sanofi; speaker’s bureau by Takeda and research support by Takeda and BMS/Celgene. JAS declares honoraria for educational events from Jazz, Gilead, Janssen, for advisory board membership from Medac, and for trial IDMC membership from Kiadis Pharma. The following authors declare that they have no conflict of interest in this manuscript: IS-O, SC, GWB, CC, RC, HD, RFD, BN, PP, ZP, IY-A and NK.